# FDA Inspection 1009264 - Stephan A. Grupp, M.D., Ph.D. - April 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/stephan-a-grupp-md-phd/16c88cce-10bf-425c-bd20-612bb21603b3
Source feed: FDA_Inspections

> FDA Inspection 1009264 for Stephan A. Grupp, M.D., Ph.D. on April 13, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009264
- Company Name: Stephan A. Grupp, M.D., Ph.D.
- Inspection Date: 2017-04-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 829992 - 2013-05-02](https://www.keypedia.com/records/fda_inspections/stephan-a-grupp-md-phd/60f92cef-de8d-4700-b015-ffd31bfbbfec)

Company: https://www.keypedia.com/companies/stephan-a-grupp-md-phd/ce88dad8-5d66-4e76-8586-09684e07e57b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d